Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOcular Therapeutix Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.30 | -$0.26 | -$0.28 |
| Q2 2026 | 4 | -$0.42 | -$0.36 | -$0.40 |
| Q3 2026 | 4 | -$0.44 | -$0.36 | -$0.40 |
| Q4 2026 | 2 | -$0.47 | -$0.34 | -$0.41 |
| Q1 2027 | 2 | -$0.47 | -$0.33 | -$0.41 |
| Q2 2027 | 1 | -$0.45 | -$0.32 | -$0.39 |
| Q3 2027 | 1 | -$0.39 | -$0.28 | -$0.34 |
| Q4 2027 | 2 | -$0.36 | -$0.25 | -$0.31 |
| Q1 2028 | 3 | -$0.18 | -$0.13 | -$0.16 |
| Q2 2028 | 2 | -$0.18 | -$0.13 | -$0.16 |
| Q3 2028 | 2 | -$0.18 | -$0.13 | -$0.16 |
| Q4 2028 | 3 | -$0.20 | -$0.14 | -$0.17 |
Ocular Therapeutix Inc Earnings Date And Information
Ocular Therapeutix Inc last posted its earnings results on Tuesday, May 5th, 2026. The company reported $-0.41 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $0.09. The company had revenue of 10.79 M for the quarter and had revenue of 51.82 M for the year. Ocular Therapeutix Inc has generated $-1 earnings per share over the last year ($-1.42 diluted earnings per share) and currently has a price-to-earnings ratio of -6.83. Ocular Therapeutix Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Ocular Therapeutix Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | -$0.32 | -$0.40 | -0.08 | $12.72 M | $10.79 M |
| 02/05/2026 | Q4 2025 | -$0.33 | -$0.29 | 0.04 | $16.13 M | $13.25 M |
| 11/04/2025 | Q3 2025 | -$0.39 | -$0.38 | 0.01 | $14.64 M | $14.54 M |
| 08/05/2025 | Q2 2025 | -$0.35 | -$0.39 | -0.04 | $13.46 M | $13.46 M |
| 05/05/2025 | Q1 2025 | -$0.29 | -$0.38 | -0.09 | $17.02 M | $10.70 M |
| 03/03/2025 | Q4 2024 | -$0.24 | -$0.29 | -0.05 | $17.15 M | $17.08 M |
| 11/14/2024 | Q3 2024 | -$0.23 | -$0.22 | 0.01 | $17.13 M | $15.43 M |
| 08/07/2024 | Q2 2024 | -$0.22 | -$0.26 | -0.04 | $15.85 M | $16.44 M |
| 05/07/2024 | Q1 2024 | -$0.18 | -$0.49 | -0.31 | $15.36 M | $14.77 M |
| 03/11/2024 | Q4 2023 | -$0.28 | -$0.21 | 0.07 | N/A | $14.80 M |
| 11/07/2023 | Q3 2023 | -$0.27 | -$0.27 | 0 | N/A | $15.08 M |
| 08/07/2023 | Q2 2023 | -$0.29 | -$0.26 | 0.03 | N/A | $15.19 M |
| 05/08/2023 | Q1 2023 | -$0.27 | -$0.39 | -0.12 | N/A | $13.37 M |
| 03/06/2023 | Q4 2022 | -$0.25 | -$0.25 | 0 | N/A | $14.08 M |
| 11/07/2022 | Q3 2022 | -$0.23 | -$0.31 | -0.08 | N/A | $11.97 M |
| 08/08/2022 | Q2 2022 | -$0.23 | -$0.27 | -0.04 | N/A | $12.27 M |
| 05/09/2022 | Q1 2022 | -$0.25 | -$0.24 | 0.01 | N/A | $13.19 M |
| 02/28/2022 | Q4 2021 | -$0.23 | -$0.24 | -0.01 | N/A | $12.31 M |
| 11/08/2021 | Q3 2021 | -$0.26 | -$0.26 | 0 | N/A | $12.15 M |
| 08/09/2021 | Q2 2021 | -$0.20 | -$0.27 | -0.07 | N/A | $11.72 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ocular Therapeutix Inc Earnings: FAQ's
The conference call for Ocular Therapeutix Inc's latest earnings report can be listened to online.
The conference call transcript for Ocular Therapeutix Inc's latest earnings report can be read online.
Ocular Therapeutix Inc (:OCUL) has a recorded annual revenue of $51.82 M.
Ocular Therapeutix Inc (:OCUL) has a recorded net income of $-265,939,000.Ocular Therapeutix Inc has generated $-1.42 earnings per share over the last four quarters.
Ocular Therapeutix Inc (:OCUL) has a price-to-earnings ratio of -6.83 and price/earnings-to-growth ratio is 0.29.